Abnormal activation of potassium channels in aortic smooth muscle of rats with peritonitis-induced septic shock

Shock

Volumn 32, Issue 1, 2009, Pages 74-79

  Kuo, Jiunn Horng ^a   Chen, Shiu Jen ^a,b   Shih, Chih Chin ^a   Lue, Wei Ming ^a   Wu, Chin Chen ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b Kang Ning Junior College of Medical Care and Management   (Taiwan)

Author keywords

Cecal ligation and puncture; NO cGMP; Potassium channels; Rat aortas

Indexed keywords

4 AMINOPYRIDINE; AMIDINE; APAMIN; BARIUM; CALCIUM CHANNEL; GLIBENCLAMIDE; IBERIOTOXIN; METHYLENE BLUE; N(G) NITROARGININE; NORADRENALIN; POTASSIUM CHANNEL; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD PRESSURE; CECUM; CELL MEMBRANE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HYPERPOLARIZATION; MALE; MEMBRANE CONDUCTANCE; MEMBRANE STEADY POTENTIAL; MYOGRAPHY; NONHUMAN; PERITONITIS; RAT; SEPTIC SHOCK; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; TENSION; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BARIUM; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; KATP CHANNELS; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; PEPTIDES; PERITONITIS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHANNELS, INWARDLY RECTIFYING; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, INBRED WKY; SHOCK, SEPTIC;

EID: 67749084504     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31818bc033     Document Type: Article

References (34)

1. Assreuy J: Nitric oxide and cardiovascular dysfunction in sepsis. Endocr Metab Immune Disord Drug Targets 6:165-173, 2006.
2. Parratt JR: Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 41:31-39, 1998.
3. Wu CC: Possible therapies of septic shock: based on animal studies and clinical trials. Curr Pharm Des 12:3535-3541, 2006.
4. + channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 224:184-190, 1996.
5. Wu CC, Chen SJ, Yen MH: Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats. Am J Physiol 275: H1148-H1157, 1998.
6. Oliver JA, Landry DW: Potassium channels and septic shock. Crit Care Med 34:1255-1257, 2006.
7. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 37:C799-C822, 1995.
8. Ignarro LJ: Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485-490, 1991.
9. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen R: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853, 1994.
10. Archer SL, Huang JM, Hampl V, Neslon DP, Schultz PJ, Weir EK: Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxinsensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 91:7583-7587, 1994.
11. +-channels in vascular hyporeactivity induced by endotoxin. Naunyn Schmiedebergs Arch Pharmacol 359:493-499, 1999.
12. + channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence. Br J Pharmacol 131:213-222, 2000.
13. Wichterman KA, Baue A, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
14. Chen SJ, Wu CC, Yen MH: Alterations in vascular reactivity in intraperitoneal sepsis. J Cardiovasc Pharmacol 24:786-793, 1994.
15. Suarez-Kurtz G, Garcia ML, Kaczorowski GJ: Effects of charybdotoxin and iberiotoxin on the spontaneous motility and tonus of different guinea pig smooth muscle tissues. J Pharmacol Exp Ther 259:439-443, 1991.
16. Rodrigo GC, Standen NB: ATP-Sensitive potassium channels. Curr Pharm Des 11:1915-1940, 2005.
17. Wu CC, Thiemermann C, Vane JR: Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol 114:1273-1281, 1995.
18. Gardiner SM, Kemp PA, March JE, Bennett T: Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol 128:1772-1778, 1999.
19. Murphy ME, Brayden JE: Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol 486:47-58, 1995.
20. Buckley JF, Singer M, Clapp LH: Role of KATP channels in sepsis. Cardiovasc Res 72:220-230, 2006.
21. O'Brien AJ, Thakur G, Buckley JF, Singer M, Clapp LH: The pore-forming subunit of the KATP channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro. Br J Pharmacol 144:367-375, 2005.
22. Loffler-Walz C, Quast U: Disruption of the actin cytoskeleton abolishes high affinity 3H-glibenclamide binding in rat aortic rings. Naunyn Schmiedebergs Arch Pharmacol 357:183-185, 1998.
23. Warrillow S, Egi M, Bellomo R: Randomized, double-blind, placebocontrolled crossover pilot study of a potassium channel blocker in patients with septic shock. Crit Care Med 34:980-985, 2006.
24. Thiemermann C: The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28:45-79, 1994.
25. Moncada S, Palmer RMJ, Higg EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
26. Fox GA, Paterson NA, McCormack DG: Effect of inhibition of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis. Am J Physiol 267:H1377-H1382, 1994.
27. Strand OA, Kirkeboen KA, Giercksky KE: Inhibition of nitric oxide synthase does not affect survival in a rat model of abdominal sepsis. Scand J Clin Lab Invest 57:105-110, 1997.
28. Vromen A, Arkovitz MS, Zingarelli B, Salzman AL, Garcia VF, Szabo C: Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 4:248-253, 1996.
29. Hamad AM, Range S, Holland E, Knox AJ: Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Am J Physiol 273:L807-L813, 1997.
30. Okamura T, Yoshida K, Toda N: Suppression by methylene blue of prostaglandin I2 synthesis in isolated dog renal arteries. J Pharmacol Exp Ther 254:198-203, 1990.
31. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G: Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 254:872-876, 1990.
32. Mayer B, Brunner F, Schmidt K: Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367-374, 1993.
33. Korovkina VP, England SK: Molecular diversity of vascular potassium channel isoforms. Clin Exp Pharmacol Physiol 29:317-323, 2002.
34. +-mediated vasodilatation. Circ Res 87:160-166, 2000.